Nothing Special   »   [go: up one dir, main page]

FI20030030A0 - Uusia yhdisteitä - Google Patents

Uusia yhdisteitä

Info

Publication number
FI20030030A0
FI20030030A0 FI20030030A FI20030030A FI20030030A0 FI 20030030 A0 FI20030030 A0 FI 20030030A0 FI 20030030 A FI20030030 A FI 20030030A FI 20030030 A FI20030030 A FI 20030030A FI 20030030 A0 FI20030030 A0 FI 20030030A0
Authority
FI
Finland
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
FI20030030A
Other languages
English (en)
Swedish (sv)
Inventor
Leena Otsomaa
Tuula Koskelainen
Arto Karjalainen
Sirpa Rasku
Piero Pollesello
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8565286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20030030(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20030030A priority Critical patent/FI20030030A0/fi
Publication of FI20030030A0 publication Critical patent/FI20030030A0/fi
Priority to ARP040100052A priority patent/AR042733A1/es
Priority to JP2006500151A priority patent/JP2006516271A/ja
Priority to US10/541,677 priority patent/US7482340B2/en
Priority to MXPA05007435A priority patent/MXPA05007435A/es
Priority to NZ541087A priority patent/NZ541087A/en
Priority to PL378326A priority patent/PL378326A1/pl
Priority to EA200501104A priority patent/EA008539B1/ru
Priority to AU2004203943A priority patent/AU2004203943B2/en
Priority to CNB200480003357XA priority patent/CN100457752C/zh
Priority to BR0406669-3A priority patent/BRPI0406669A/pt
Priority to YUP-2005/0528A priority patent/RS20050528A/sr
Priority to EP04701023A priority patent/EP1583759A1/en
Priority to PCT/FI2004/000011 priority patent/WO2004063191A1/en
Priority to CA002512184A priority patent/CA2512184A1/en
Priority to KR1020057012621A priority patent/KR20050095601A/ko
Priority to UAA200507847A priority patent/UA81941C2/uk
Priority to IL169435A priority patent/IL169435A0/en
Priority to IS7969A priority patent/IS7969A/is
Priority to NO20053730A priority patent/NO20053730L/no
Priority to HR20050703A priority patent/HRP20050703A2/hr
Priority to ZA200505461A priority patent/ZA200505461B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI20030030A 2003-01-09 2003-01-09 Uusia yhdisteitä FI20030030A0 (fi)

Priority Applications (22)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä
ARP040100052A AR042733A1 (es) 2003-01-09 2004-01-08 Derivados de piridinas utilizados como inhibidores del mecanismo de intercambio na+/ca2+
CA002512184A CA2512184A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
KR1020057012621A KR20050095601A (ko) 2003-01-09 2004-01-09 소디움/칼슘 교환시스템 억제에 유용한 피리딘 유도체들
CNB200480003357XA CN100457752C (zh) 2003-01-09 2004-01-09 用于抑制钠/钙交换体系的吡啶衍生物
YUP-2005/0528A RS20050528A (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
MXPA05007435A MXPA05007435A (es) 2003-01-09 2004-01-09 Derivados de piridina utiles para inhibir el sistema de intercambio de sodio/calcio.
NZ541087A NZ541087A (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
PL378326A PL378326A1 (pl) 2003-01-09 2004-01-09 Pochodne pirydyny użyteczne do inhibitowania układu wymiany sód/wapń
EA200501104A EA008539B1 (ru) 2003-01-09 2004-01-09 Производные пиридина, пригодные для ингибирования системы обмена натрия/кальция
AU2004203943A AU2004203943B2 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
JP2006500151A JP2006516271A (ja) 2003-01-09 2004-01-09 ナトリウム／カルシウム交換系の阻害に有用なピリジン誘導体
BR0406669-3A BRPI0406669A (pt) 2003-01-09 2004-01-09 Derivados de piridina úteis para inibir sistema de troca de sódio/cálcio
US10/541,677 US7482340B2 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
EP04701023A EP1583759A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
PCT/FI2004/000011 WO2004063191A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
UAA200507847A UA81941C2 (uk) 2003-01-09 2004-09-01 Похідні піридину, придатні для інгібування системи обміну натрію/кальцію
IL169435A IL169435A0 (en) 2003-01-09 2005-06-28 Pyridine derivatives useful for inhibiting sodium / calcium exchange system
IS7969A IS7969A (is) 2003-01-09 2005-08-02 Pýridínafleiður sem eru gagnlegar við að hamla natríum/kalsíumskiptikerfi
NO20053730A NO20053730L (no) 2003-01-09 2005-08-03 Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem
HR20050703A HRP20050703A2 (en) 2003-01-09 2005-08-08 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
ZA200505461A ZA200505461B (en) 2003-01-09 2006-01-24 Pyridine derivatives usefl for inhibiting sodium/calcium exchange system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä

Publications (1)

Publication Number Publication Date
FI20030030A0 true FI20030030A0 (fi) 2003-01-09

Family

ID=8565286

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä

Country Status (22)

Country Link
US (1) US7482340B2 (fi)
EP (1) EP1583759A1 (fi)
JP (1) JP2006516271A (fi)
KR (1) KR20050095601A (fi)
CN (1) CN100457752C (fi)
AR (1) AR042733A1 (fi)
AU (1) AU2004203943B2 (fi)
BR (1) BRPI0406669A (fi)
CA (1) CA2512184A1 (fi)
EA (1) EA008539B1 (fi)
FI (1) FI20030030A0 (fi)
HR (1) HRP20050703A2 (fi)
IL (1) IL169435A0 (fi)
IS (1) IS7969A (fi)
MX (1) MXPA05007435A (fi)
NO (1) NO20053730L (fi)
NZ (1) NZ541087A (fi)
PL (1) PL378326A1 (fi)
RS (1) RS20050528A (fi)
UA (1) UA81941C2 (fi)
WO (1) WO2004063191A1 (fi)
ZA (1) ZA200505461B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
UA102514C2 (ru) * 2007-02-22 2013-07-25 Сингента Партисипейшнс Аг Производные иминопиридина, промежуточное соединение, способ борьбы с заражением полезных растений грибами или его предупреждение и композиция на основе производной иминопиридина
CA2817205C (en) * 2010-12-06 2020-04-07 Autifony Therapeutics Limited Hydantoin derivatives useful as kv3 inhibitors
EP2524908A1 (en) * 2011-05-20 2012-11-21 LEK Pharmaceuticals d.d. Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
PT2567958E (pt) 2011-09-12 2015-01-14 Sanofi Sa 2-(croman-6-iloxi)-tiazoles substituídos e sua utilização como produtos farmacêuticos
KR101817925B1 (ko) 2011-09-12 2018-01-12 사노피 치환된 ２-（크로만-６-일옥시）-티아졸 및 약제로서의 이의 용도
WO2013144191A1 (de) * 2012-03-29 2013-10-03 Bayer Intellectual Property Gmbh Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
TWI633095B (zh) 2013-03-08 2018-08-21 賽諾菲公司 經取代－６－基氧基－環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
CN107624110B (zh) 2015-03-06 2021-01-26 法玛克亚公司 赖氨酰氧化酶样2抑制剂及其用途
CA2977947A1 (en) 2015-03-06 2016-09-15 Pharmakea, Inc. Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
JP6856021B2 (ja) * 2015-08-19 2021-04-07 日産化学株式会社 液晶配向剤などに用いられる新規なイミド系重合体
MA46204A (fr) 2016-09-07 2021-03-17 Pharmakea Inc Formes cristallines d'un inhibiteur de lysyl oxydase de type 2 et leurs procédés de fabrication
CN109922803B (zh) 2016-09-07 2023-09-22 法玛克亚公司 赖氨酰氧化酶样2抑制剂的用途
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
KR20230058399A (ko) 2020-07-28 2023-05-03 재즈 파마슈티칼즈 아일랜드 리미티드 융합된 바이사이클릭 raf 억제제 및 이의 사용 방법
CN115850258B (zh) * 2022-12-27 2024-09-24 东北林业大学 一种马赛替尼的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
US3862232A (en) 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
BE650081A (fi) 1963-07-03
GB1154119A (en) 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
JPH04113839A (ja) * 1990-09-05 1992-04-15 Mitsubishi Petrochem Co Ltd ポリカーボネート樹脂積層物
FR2733685B1 (fr) 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
KR20010005632A (ko) 1997-03-27 2001-01-15 우에하라 아끼라 2-페녹시아닐린 유도체
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
ES2191341T3 (es) 1997-10-20 2003-09-01 Taisho Pharmaceutical Co Ltd Derivados de la 2-fenoxianilina.
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
CA2370607A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
RU2234502C2 (ru) 1999-09-17 2004-08-20 Ниссан Кемикал Индастриз, Лтд. Бензопирановое производное и лекарственное средство на его основе
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
BRPI0406669A (pt) 2005-12-20
PL378326A1 (pl) 2006-03-20
US7482340B2 (en) 2009-01-27
CN100457752C (zh) 2009-02-04
EP1583759A1 (en) 2005-10-12
AR042733A1 (es) 2005-06-29
IS7969A (is) 2005-08-02
HRP20050703A2 (en) 2005-10-31
AU2004203943A1 (en) 2004-07-29
NZ541087A (en) 2008-04-30
WO2004063191A1 (en) 2004-07-29
US20060241147A1 (en) 2006-10-26
IL169435A0 (en) 2007-07-04
MXPA05007435A (es) 2005-09-12
RS20050528A (en) 2007-06-04
EA008539B1 (ru) 2007-06-29
AU2004203943B2 (en) 2009-09-17
ZA200505461B (en) 2006-03-29
JP2006516271A (ja) 2006-06-29
KR20050095601A (ko) 2005-09-29
EA200501104A1 (ru) 2005-12-29
NO20053730D0 (no) 2005-08-03
CN1745078A (zh) 2006-03-08
UA81941C2 (uk) 2008-02-25
NO20053730L (no) 2005-10-07
CA2512184A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
IS8108A (is) Ný efnasambönd
DK1605897T3 (da) Polyethelen-glycol-link-glp-1-forbindelser
SE0302305D0 (sv) Novel Compounds
IS8228A (is) Ný asetídínefnasambönd
IS7471A (is) Ný efnasambönd
IS7879A (is) Ný efnasambönd
IS8292A (is) Ný efnasambönd
FI20030030A0 (fi) Uusia yhdisteitä
AT502792A5 (de) Düsenanpressvorrichtung
IS7827A (is) Ný efnasambönd
IS8089A (is) Efnasambönd
DK1633719T3 (da) Substituerede spirobenzazepiner
DE502004009935D1 (de) Substituierte dihydrochinazoline ii
NO20031736D0 (no) Forbindelser
SE0303452D0 (sv) New compounds
AT6592U3 (de) Frontgrubber
SE0300357D0 (sv) New compounds
SE0303181D0 (sv) New compounds
SE0301120D0 (sv) New compounds
SE0301246D0 (sv) New compounds
SE0302369D0 (sv) New compounds
SE0302368D0 (sv) New compounds
SE0301305D0 (sv) New compounds
SE0303078D0 (sv) New compounds
SE0303493D0 (sv) New compounds